Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018
Authors' conclusion
Our findings provide evidence of racial and ethnic disparities in newer GLD use and quality of care in glucose management. Our study results can inform decision-makers of the status of racial and ethnic disparities and identify ways to reduce these disparities.
Study context
- Population
- US adults ≥18 years with diabetes, 2005–2018
- Exposure
- Non-Hispanic black, Hispanic and other race/ethnicity vs non-Hispanic white adults
- Outcome
- Newer GLD use
- Follow-up
- 2018
Methodological detailsMEPS and NHANES 2005-2018 data
- MEPS and NHANES 2005-2018 data
Main finding
As reported in the abstract
Adjusted risk ratio
0.44
P < 0.05 for all
Non-Hispanic black
Adjusted risk ratio
0.52
P < 0.05 for all
Hispanic
Adjusted risk ratio
0.64
P < 0.05 for all
Other race/ethnicity
Observational data: associations, not effects.
Further findings
| Outcome | Estimate | P value |
|---|---|---|
| Insulin analogue use · 2018Non-Hispanic black vs Non-Hispanic white | adjusted risk ratio 0.93 | P < 0.05 |
| Insulin analogue use · 2018Hispanic vs Non-Hispanic white | adjusted risk ratio 0.89 | P < 0.05 |
| Insulin analogue use · 2018Other race/ethnicity vs Non-Hispanic white · not significant (p < .05 for all except other groups) | adjusted risk ratio 0.95 | |
| Non-insulin GLD adherence (proportion of days covered) · 2018Non-Hispanic black vs Non-Hispanic white | difference −4.5 % | P < 0.05 for all |
| Non-insulin GLD adherence (proportion of days covered) · 2018Hispanic vs Non-Hispanic white | difference −5.6 % | P < 0.05 for all |
| Non-insulin GLD adherence (proportion of days covered) · 2018Other race/ethnicity vs Non-Hispanic white | difference −4.3 % | P < 0.05 for all |
| HbA1c · 2018Non-Hispanic black vs Non-Hispanic white | difference 0.29 % | P < 0.05 |
| HbA1c · 2018Hispanic vs Non-Hispanic white | difference 0.32 % | P < 0.05 |
| HbA1c · 2018Other race/ethnicity vs Non-Hispanic white · not significant (p < .05 for all except other group) | difference 0.02 % |
Insulin adherence · 2018
- Similar insulin adherence across racial and ethnic groups
Contributors to disparities
- Socioeconomic and health status were the main contributors to these disparities
Original publication
Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018. Diabetes Obes Metab. Published 2 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →